Regeneron Pharmaceuticals, Inc.
Explore Regeneron Pharmaceuticals, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Regeneron Pharmaceuticals, Inc.
Explore Regeneron Pharmaceuticals, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2025 Revenue
$14.3B
▲ 0.7% vs FY2024 ($14.2B)
Net Income: $4.4B
Source: Annual report / company filing
Regeneron Pharmaceuticals, Inc. reported $14.3B in revenue for fiscal year 2025. This represents a growth of 0.7% compared to the 2024 figure of $14.2B.
Revenue edged up just 0.7% to $14.3 billion in 2025 as EYLEA sales fell under biosimilar competition, roughly offsetting Dupixent and EYLEA HD gains after the COVID antibody tailwind had faded.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.